Skip to main content
Caplight Logo









Synceres Biosciences

Synceres Biosciences

Private
ShenzhenHealthcare & Life Scienceshttps://www.synceres.com/

Last Round

Series A

Extension

Jun 15, 2023

Total Funding Raised

$14.92M

Company Overview

Synceres Biosciences is a synthetic biology company that develops and produces bio-based ingredients for industries including biomedicine, health food, and industrial chemicals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

synthetic biologydrug discoverybiotech R&Dcontract manufacturingbiomedicineoncology therapeuticsimmunology therapeuticssmall moleculebiologic therapeuticsCDMOdrug licensingmetabolic engineeringOEMODMbio-foundrypreclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synceres Biosciences Comparables

Compare Synceres Biosciences with similar companies based on industry and business-model similarity.

Synceres Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AbSci
68%
Abiochem Biotechnology
56%
GenScript
55%

Synceres Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJun 15, 2023
Series AMar 16, 2022
AngelOct 22, 2020
Pre SeedJul 24, 2019

Synceres Biosciences Investors

Notable investors and investment history

Synceres Biosciences investors
InvestorRounds
Bloomage International GroupSeries A Extension
Tasly Holding GroupSeries A Extension
Shenzhen New Henglida Capital ManagementPre Seed, Series A Extension
CoStone CapitalSeries A Extension
Shenzhen HTI GroupSeries A
Shenzhen Capital GroupPre Seed, Angel, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 16, 2022

    $15M round led by Shenzhen Capital Group

  • Oct 22, 2020

    Shenzhen Capital Group led the Angel round.

Synceres Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synceres Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synceres Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Year Founded2019
Last FundingJun 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?